b'Appendices Appendix 4 GENOME CANADA Notes to Financial Statements (continued)Year ended March 31, 2019 (in thousands of dollars) 12. Financial risk management (continued):(e)Other price risk: Other price risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market prices. The fair value of investments is disclosed in note 3 to the financial statements. The Corporation is not subject to significant risks from its financial instruments. There has been no significant change in the risk exposures of the Corporation compared to the fiscal year 2018. 14 14'